1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
Wu, Jia-Zhen ; Ardah, Mustafa ; Haikal, Caroline LU ; Svanbergsson, Alexander LU
; Diepenbroek, Meike
LU
; Vaikath, Nishant N
LU
; Li, Wen
LU
; Wang, Zhan-You
; Outeiro, Tiago F
and El-Agnaf, Omar M
, et al.
(2019)
In Translational Neurodegeneration
8.
Mark
- 2017
- Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
- 2016
- A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
- Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
- 2015
- Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
- Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.